Research led by investigators at Memorial Sloan-Kettering Cancer Centre has shown that therapeutic cloning, also known as somatic-cell nuclear transfer, can be used to treat Parkinson's disease in mice.
Research shows therapeutic cloning can be used to treat Parkinson's disease in mice